Acknowledgements

This portal could not have been developed without the support of several people. We would like to acknowledge the following people for their contributions.

EUFOREA Core team

  • Dr Sophie Scheire (project lead, coordinator, content development)
  • Tania Lopes (audiovisual content and portal development)
  • Stéphanie Gailly (audiovisual content and portal development)
  • Remie Bruggeman (audiovisual content)
  • Dr Xander Bertels (proof-reading)
  • Vanessa Stockton (proof-reading)
  • Katie Tassell (proof-reading)
  • Lieve Celis (proof-reading)
  • Dr Diego Conti (proof-reading)
  • Prof Dr Peter Hellings (project supervisor)

Additionally, a special thanks to following experts for their role in the development of the Expert videos.

  • Mrs Ellen Bonne (Ghent University Hospital, Ghent, Belgium)
  • Prof Dr Leen De Bolle (Ghent University, Belgium)
  • Prof Dr Adam Fox (King’s College London, United Kingdom)
  • Prof Dr Philippe Gevaert (Ghent University Hospital, Belgium)
  • Dr Marinda Mcdonald (Allergy Clinic, Randburg, South-Africa)
  • Prof Dr Anju T Peters (Northwestern University Feinberg School of Medicine, United States)
  • Prof Dr Sietze Reitsma (Amsterdam Medical Centre, the Netherlands)
  • Dr Dermot Ryan (Honorary researcher, University of Edinburgh; Board member of International Primary Care Respiratory Group, UK)
  • Prof Dr Glenis Scadding (Royal National ENT Hospital, London, United Kingdom)
  • Dr Guy Scadding (Royal Brompton Hospital, London, United Kingdom)

We would like to extend a special thanks to following experts of the EUFOREA Rhinitis Expert Panel for the review of the content:

  • Prof Dr Michael Blaiss (Clinical Professor of Allergy/Immunology, Medical College of Georgia, US)
  • Dr Elena Borzova (University of East Anglia, United Kingdom)
  • Prof Dr Lars-Olaf Cardell (Karolinska Institutet, Stockholm, Sweden)
  • Prof Dr Wytske Fokkens (Amsterdam University Medical Centres, the Netherlands)
  • Prof Dr David Price (University of Aberdeen, United Kingdom)
  • Prof Dr Glenis Scadding (Royal National ENT Hospital, London, United Kingdom)
  • Dr Guy Scadding (Royal Brompton Hospital, London, United Kingdom)
  • Prof Dr Pete Smith (Queensland Allergy Services, Southport, Queensland, Australia)

Funding

The EUFOREA Allergic Rhinitis Patient Portal is supported by an unrestricted grant by Eli Lilly. EUFOREA has and maintains full editorial control over the content and publication decisions.

References

  • EUFOREA Allergic Rhinitis Pocket Guide: www.euforea.org
  • EUFOREA CRS and Asthma Patient Portal. Available from www.euforea.org/patient-portal
  • Allergic Rhinitis and Its Impact on Asthma (2008) and updates:

    Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160. doi:10.1111/j.1398-9995.2007.01620.x

    B.Sousa-Pinto, J.Bousquet, R. J.Vieira, et al., “Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments,” Allergy (2025): 1–23
  • Rhinitis Practice Parameter 2020: Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020;146(4):721-767. doi:10.1016/j.jaci.2020.07.007
  • UpToDate – Patient Education: Allergic Rhinitis (Beyond the basics). Available from www.uptodate.com
  • UpToDate – Food allergy in children: Prevalence, natural history, and monitoring for resolution. Available from www.uptodate.com
  • Cleveland Clinic - Allergic Rhinitis (Hay Fever). Available from https://my.clevelandclinic.org/health/diseases/8622-allergic-rhinitis-hay-fever
  • Mayo Clinic – Hay Fever. Available from: https://www.mayoclinic.org/diseases-conditions/hay-fever/symptoms-causes/syc-20373039
  • Mayo Clinic – Allergies. Available from: https://www.mayoclinic.org/diseases-conditions/allergies/in-depth/allergy-medications/art-20047403
  • American Academy of Allergy Asthma & Immunology – Allergy Statistics. Available from: https://www.aaaai.org/about/news/for-media/allergy-statistics
  • Australasian Society of Clinical Immunology and Allergy (ASCIA) – Available from: https://www.allergy.org.au/patients/about-allergy/common-myths-about-allergy-and-asthma
  • Akhouri S, House SA. Allergic Rhinitis. [Updated 2023 Jul 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538186/
  • Lourenço O, Bosnic-Anticevich S, et al. Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice. Pharmacy (Basel). 2020 May 16;8(2):85. doi: 10.3390/pharmacy8020085. PMID: 32429362; PMCID: PMC7355936.
  • Torres MI, Gil-Mata S, Bognanni A, et al. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis. J Allergy Clin Immunol Pract. 2024;12(12):3404-3418. doi:10.1016/j.jaip.2024.09.001

A complete list of the scientific publications used to develop the content of this patient portal is available upon request.

Logbook

March 31, 2026: Launch of the AR module on the Patient Portal

 

The information, including but not limited to, text, graphics, images, and other material contained on this website is for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment and/or medical treatment of a qualified physician or healthcare provider. EUFOREA is not a medical organisation and cannot provide specific medical advice to patients via the Internet and/or E-mail. All patients are encouraged to direct their specific questions to their personal physicians. EUFOREA presents this information to patients so that patients can understand and participate in their own medical care. EUFOREA strongly emphasises that the information contained on this website is not a substitute for thorough evaluation and treatment by a qualified healthcare provider.

© 2025 - EUFOREA - All rights reserved. All content on this portal, such as text, graphics, logos and images, is the property of EUFOREA. They may not be reproduced, copied, published, stored, modified or used in any form, online or offline, without prior written permission of EUFOREA.

Overview

button-block-bgcheckcheckmarkCME badgeCMEcmebadgeCMEdownloadeuforeatveyefacebookfaqglobeicon_1icon_2icon_3Middel 1iconmonstr-facebook-1iconmonstr-info-8iconmonstr-linkedin-1iconmonstr-twitter-1iconmonstr-video-13iconmonstr-youtube-1infographic-blueinfographic-blueinfographic-bulbinfographic-darkblueinforgraphic-yellowinstagramlinkedinpdfpinterestquestionmarksmartphonespotifytweetstwitteryoutube